Evidence map›Paper›PMID 26398194›Full record

ArticlePloS one2015

Comparative Analysis of the Orphan CRISPR2 Locus in 242 Enterococcus faecalis Strains.

Karthik Hullahalli, Marinelle Rodrigues, Brendan D Schmidt, Xiang Li, Pooja Bhardwaj, Kelli L Palmer

Abstract readComparative Study
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Hidden diversity inMicrobiology spectrum · 2025
    Article
  4. Article
  5. CRISPR-Cas systems in enterococci.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  6. Article
  7. Article
  8. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. CRISPR Arrays Away fromThe CRISPR journal · 2020
    Article
  16. Article
  17. Viruses · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Karthik HullahalliDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, United States of America.
Marinelle RodriguesDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, United States of America.
Brendan D SchmidtDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, United States of America.
Xiang LiDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, United States of America.
Pooja BhardwajDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, United States of America.
Kelli L PalmerDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, Texas, United States of America.

Funding

CRISPR defense and acquired antibiotic resistance in Enterococcus faecalisK22AI099088 · NIAID · UNIVERSITY OF TEXAS DALLAS · PI PALMER, KELLI LEA · 2013 to 2014
$264k
NIAID NIH HHS K22 AI099088NIAID NIH HHS K22AI099088
6 · The paper itself

Abstract

Clustered, Regularly Interspaced Short Palindromic Repeats and their associated Cas proteins (CRISPR-Cas) provide prokaryotes with a mechanism for defense against mobile genetic elements (MGEs). A CRISPR locus is a molecular memory of MGE encounters. It contains an array of short sequences, called spacers, that generally have sequence identity to MGEs. Three different CRISPR loci have been identified among strains of the opportunistic pathogen Enterococcus faecalis. CRISPR1 and CRISPR3 are associated with the cas genes necessary for blocking MGEs, but these loci are present in only a subset of E. faecalis strains. The orphan CRISPR2 lacks cas genes and is ubiquitous in E. faecalis, although its spacer content varies from strain to strain. Because CRISPR2 is a variable locus occurring in all E. faecalis, comparative analysis of CRISPR2 sequences may provide information about the clonality of E. faecalis strains. We examined CRISPR2 sequences from 228 E. faecalis genomes in relationship to subspecies phylogenetic lineages (sequence types; STs) determined by multilocus sequence typing (MLST), and to a genome phylogeny generated for a representative 71 genomes. We found that specific CRISPR2 sequences are associated with specific STs and with specific branches on the genome tree. To explore possible applications of CRISPR2 analysis, we evaluated 14 E. faecalis bloodstream isolates using CRISPR2 analysis and MLST. CRISPR2 analysis identified two groups of clonal strains among the 14 isolates, an assessment that was confirmed by MLST. CRISPR2 analysis was also used to accurately predict the ST of a subset of isolates. We conclude that CRISPR2 analysis, while not a replacement for MLST, is an inexpensive method to assess clonality among E. faecalis isolates, and can be used in conjunction with MLST to identify recombination events occurring between STs.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsEnterococcus faecalisEvolution, MolecularGenes, BacterialMultilocus Sequence TypingPhylogenyPolymorphism, Single Nucleotide

Identifiers

PMID26398194
PMCPMC4580645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.